Tuesday, January 8, 2008

More on Cholesterol and Entry Antagonism

On a previous post, we discussed Samaritan Pharmaceutical's HIV chemokine receptor inhibitor based on cortisol inhibition and its resulting cellular cholesterol level reduction. Another study corroborates the dependence of CCR5 and CXCR4 chemokine receptors on the presence of cholesterol if HIV is to attach to them.

No comments: